시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 생식기 사마귀 시장 보고서(2025년)
Genital Warts Global Market Report 2025
상품코드 : 1825747
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,430,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,294,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,159,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

생식기 사마귀 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 CAGR 5.1%로 25억 2,000만 달러로 성장할 것입니다. 예측 기간의 성장은 원격진료 및 치료 모니터링을 위한 원격의료 및 디지털 건강 플랫폼의 채택, STI에 대한 효과적이고 저렴한 치료법에 대한 수요 증가, 루프 전기 수술 절제술의 인기 증가, 인터페론 알파-n3 주사에 대한 수요 증가, 치료약물의 치료제의 가용성 증가 등에 기인하는 것으로 추정됩니다. 예측 기간의 주요 동향으로는 진단 기술의 발전, 병용요법으로의 전환, 원격의료와 온라인 진료의 확대, 새로운 치료 타겟의 출현, 신흥 시장에서의 확대 등을 꼽을 수 있습니다.

향후 5년간 5.1%의 성장률 전망은 지난번 전망치보다 0.3% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 장벽은 캐나다와 스위스에서 조달하는 냉동치료 장비와 이미키모도 크림의 비용을 상승시키고, 인유두종바이러스(HPV) 관련 병변의 치료 효과를 떨어뜨리고, 피부과 클리닉의 지출을 증가시킴으로써 미국을 저해할 것으로 예상됩니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

성병(STI) 유병률의 증가는 생식기 사마귀 시장의 성장을 촉진할 것으로 예상됩니다. STI는 주로 질, 항문, 구강 등 성접촉을 통해 감염되며 세균, 바이러스, 기생충에 의해 발생합니다. STI 유병률의 증가는 성행위의 증가, 보호 장비의 불충분한 사용, 교육 및 의료 서비스 이용의 제한에 기인합니다. 흔한 STI인 생식기 사마귀는 인유두종바이러스(HPV)의 특정 균주에 의해 발생하며, 성행위 중 피부와 피부의 직접적인 접촉을 통해 전파됩니다. 예를 들어, 스위스에 본부를 둔 유엔 합동 에이즈 프로그램(Joint United Nations Programme on HIV/AIDS)은 2023년 10월, HIV 감염자가 2021년 3,870만 명에서 2022년 3,900만 명으로 증가하고, 2022년에는 130만 명이 새로 감염될 것이라고 보고했습니다. 이러한 STI의 확산은 생식기 사마귀 시장의 확대에 박차를 가하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSM
영문 목차

영문목차

Genital warts, also known as condylomata acuminata, are sexually transmitted infections caused by specific strains of the human papillomavirus (HPV). These warts typically manifest as small growths or clusters of bumps in or around the genital and anal areas. They can vary in size and shape, may be raised or flat, and often have a cauliflower-like appearance. Although generally painless, genital warts can lead to itching, discomfort, or bleeding during sexual intercourse.

The primary medications for treating genital warts include imiquimod, podophyllin, podofilox, and trichloroacetic acid. Imiquimod is a topical cream that works by stimulating the immune system to combat HPV-related warts. Treatment options also encompass chemical treatments, ablative treatments, preventive treatments, and other therapeutic approaches. These treatments are used by both females and males in various settings, such as hospitals, clinics, and home care environments.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The genital warts market research report is one of a series of new reports from The Business Research Company that provides genital warts market statistics, including genital warts industry global market size, regional shares, competitors with a genital warts market share, detailed genital warts market segments, market trends and opportunities, and any further data you may need to thrive in the genital warts industry. This genital warts market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The genital warts market size has grown steadily in recent years. It will grow from $1.97 billion in 2024 to $2.06 billion in 2025 at a compound annual growth rate (CAGR) of 4.7%. The growth in the historic period can be attributed to the focus on patient-centered care, growing emphasis on early detection and treatment, increasing availability of therapies developed for self-target applications, and the increase in clinical trials and recurrence of genital warts.

The genital warts market size is expected to see strong growth in the next few years. It will grow to $2.52 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to the adoption of telemedicine and digital health platforms for remote consultation and treatment monitoring, growing demand for effective and affordable treatments for STIs, the emerging popularity of loop electrosurgical excision procedures, the escalating demand for interferon alfa-n3 injection and increasing availability of therapies. Major trends in the forecast period include advancements in diagnostic technologies, a shift towards combination therapies, expansion of telehealth and online consultations, emergence of novel therapeutic targets, and expansion in emerging markets.

The forecast of 5.1% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of cryotherapy devices and imiquimod cream sourced from Canada and Switzerland, thereby reducing treatment efficacy for Human Papillomavirus(HPV)-related lesions and elevating dermatology clinic expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of sexually transmitted infections (STIs) is expected to drive growth in the genital warts market. STIs, transmitted primarily through sexual contact such as vaginal, anal, and oral sex, are caused by bacteria, viruses, or parasites. The increase in STI prevalence is attributed to higher sexual activity, insufficient use of protection, and limited access to education and healthcare. Genital warts, a common STI, are caused by specific strains of human papillomavirus (HPV) and spread through direct skin-to-skin contact during sexual activity. For example, the Joint United Nations Programme on HIV/AIDS, based in Switzerland, reported in October 2023 that HIV infections rose from 38.7 million in 2021 to 39.0 million in 2022, with 1.3 million new infections in 2022. This growing prevalence of STIs is fueling the expansion of the genital warts market.

Companies in the genital warts market are focusing on developing innovative treatment options, such as new dermatology drugs, to address the needs of patients with genital warts. Dermatology drugs are newly developed pharmaceuticals aimed at treating various skin conditions, including genital warts. For instance, in March 2023, Verrica Pharmaceuticals Inc., a US-based dermatology company, received New Chemical Entity (NCE) status from the FDA for its drug candidate YCANTH. YCANTH, which has completed phase 2 trials, is being developed to treat genital warts and will benefit from at least five years of protection from generic competition due to its NCE status.

In April 2024, Endo, Inc., a US-based pharmaceutical company specializing in generics and specialty-branded products, acquired Endo International plc for an undisclosed amount. This acquisition aims to bolster Endo, Inc.'s portfolio in both generic and specialty pharmaceuticals, enhancing its ability to support patients and healthcare providers. Endo International plc is also a US-based company specializing in generics and specialty-branded pharmaceuticals.

Major companies operating in the genital warts market are Merck & Co.Inc., AbbVie Inc, Sanofi S.A, Novartis AG, 3M Company, Teva Pharmaceutical Industries Ltd, Bausch Health Companies Inc, Sun Pharmaceuticals, Perrigo Company plc, Glenmark Pharmaceutical Inc, Taro Pharmaceutical Industries Ltd, Serum Institute of India Pvt. Ltd., ANI Pharmaceuticals Inc, Ligand Pharmaceuticals Incorporated, Orgenesis Inc, Verrica Pharmaceuticals Inc, CryoConcepts LP, CryoIQ global AB, Cassiopea Inc, Aresus Pharma Inc.

North America was the largest region in the genital warts market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genital warts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the genital warts market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The genital warts market consists of revenues earned by entities by providing services such as medical consultations, diagnostic testing, treatment procedures, follow-up care, and patient education programs. The market value includes the value of related goods sold by the service provider or included within the service offering. The genital warts market also includes sales of topical treatments, cryotherapy devices, surgical instruments, immune response modifiers, and antiviral medications. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Genital Warts Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on genital warts market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for genital warts ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The genital warts market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Genital Warts Market Characteristics

3. Genital Warts Market Trends And Strategies

4. Genital Warts Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Genital Warts Growth Analysis And Strategic Analysis Framework

6. Genital Warts Market Segmentation

7. Genital Warts Market Regional And Country Analysis

8. Asia-Pacific Genital Warts Market

9. China Genital Warts Market

10. India Genital Warts Market

11. Japan Genital Warts Market

12. Australia Genital Warts Market

13. Indonesia Genital Warts Market

14. South Korea Genital Warts Market

15. Western Europe Genital Warts Market

16. UK Genital Warts Market

17. Germany Genital Warts Market

18. France Genital Warts Market

19. Italy Genital Warts Market

20. Spain Genital Warts Market

21. Eastern Europe Genital Warts Market

22. Russia Genital Warts Market

23. North America Genital Warts Market

24. USA Genital Warts Market

25. Canada Genital Warts Market

26. South America Genital Warts Market

27. Brazil Genital Warts Market

28. Middle East Genital Warts Market

29. Africa Genital Warts Market

30. Genital Warts Market Competitive Landscape And Company Profiles

31. Genital Warts Market Other Major And Innovative Companies

32. Global Genital Warts Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Genital Warts Market

34. Recent Developments In The Genital Warts Market

35. Genital Warts Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기